Dier Mardi 4
4 · MADRIGAL PHARMACEUTICALS, INC. · Filed Mar 2, 2026
Research Summary
AI-generated summary of this filing
Madrigal CFO Dier Mardi Sells 1,183 Shares
What Happened Dier Mardi, Executive Vice President and Chief Financial Officer of Madrigal Pharmaceuticals (MDGL), sold 1,183 shares on 2026-03-02 at $427.21 per share, generating proceeds of $505,389. The filing indicates the sale was executed to satisfy tax withholding obligations tied to the vesting of restricted stock units, not as a discretionary open-market trade.
Key Details
- Transaction date and price: 2026-03-02 at $427.21 per share
- Shares sold / proceeds: 1,183 shares / $505,389 total
- Shares owned after transaction: Not reported in this Form 4
- Footnote: Sale was automatic to cover tax withholding for vested RSUs (not at the reporting person’s discretion)
- Filing timeliness: Reported on 2026-03-02 (same-day filing; no late filing indicated)
Context This was a routine "sell to cover" tied to RSU vesting, a common administrative transaction to satisfy tax liabilities. Such sales are not strong indicators of insider sentiment because they are mandatory or automated rather than voluntary stock-selling decisions.
Insider Transaction Report
- Sale
Common Stock
[F1]2026-03-02$427.21/sh−1,183$505,389→ 9,257 total
Footnotes (1)
- [F1]This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.